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Summary
The minimal region of the human tumor necrosis factor a (TNF-a) gene promoter necessary
for its transcriptional induction by phorbol esters (PMA) in human T and B lymphocyte cell
lineshasbeen localized between -52 and +89 nucleotides (nt) relative to the gene's transcriptional
start site. Comparison of these sequences to those required to mediate virus or lipopolysaccharide
(LPS) induction of the gene reveal significant differences, and thus, the sequence requirements
for PMA induction are distinct from those that mediate induction by virus or LPS. Although
three sites in the TNF-a promoter (tc1, tt2, and tc3) specifically bind the transcription factor
NF-KB in lymphoid nuclear extracts, TNF-a mRNA induction by PMA does not correlate with
NF-KB binding activities displayed by different T and B cell lines. Moreover, K1-K3 can each
be deleted from the TNF-a promoter with little effect on the gene's inducibility by PMA. Therefore,
TNF-a mRNA induction by PMA, like its induction by virus and LPS, is not primarily mediated
by - NF-KB, but rather is mediated through other sequences and protein factors. Surprisingly,
multimers of «1-tc3 can confer PMA inducibility on a heterologous promoter in a B (Raji), but
not a T (HUT78) cell line. However they are not functional on a truncated TNF-a promoter,
indicating that promoter context and cell type specificity influence the PMA inducible function
of these NF-KB binding sites.
H
uman TNF-a is a cytotoxic protein that displays a wide
range of biological activities that include the hemor-
rhagic necrosis of certain tumors, inhibition of viral infec-
tion and a role in the mediation of septic shock (see refer-
ences 1 and 2 for review). Historically thought to be a
monocyte derived factor, TNF-ca is also produced by circulating
human peripheral B lymphocytes (3) and tonsillar B lym-
phocytes (4) . In addition, certain human B cell lines produce
TNF-a when stimulated by virus (3) and PMA (3, 4). T
cell lines have also been shown to produce TNF-a when stim-
ulated by virus and PMA as well as by other T cell activating
agents such as anti-CD3 antibody and calcium ionophore
(5, 6).
PMA treatment of T and B lymphocytes stimulates pro-
tein kinase C activity and therefore provides a model system
oflymphocyte activation (7). Induction of TNF-a in B cells
and T cells by PMA and other inducers is also of interest
in light of the role TNF-a itself plays in the activation and
differentiation oflymphocytes and in associated processes. For
example, TNF-a promotes T cell growth and differentiation
of T cells via induction of IIT2R (8), and stimulates B cell
growth and differentiation through its induction of 11,6 (9) .
In addition, TNF-a increases the expression of HIV in cer-
tain latently infected T cell lines (reviewed in reference 10).
These effects are presumably mediated through the induc-
tion of a variety oftranscription factors by TNF-a including
T cell derived proteins that bind to NF-KB binding sites (11-13)
and the growth factors fos andjun (14). The understanding
of TNF-ca gene regulation by PMA in B and T lymphocytes
may therefore provide insight into these processes of lym-
phocyte and HIV-1 activation, as well as into mechanisms
of inducible gene expression by PMA.
In addition to PMA, virus and LPS are also potent inducers
ofhuman TNF-a gene transcription (2, 3). These induction
processes are however distinguishable at the level of transcrip-
tion. For example, virus, LPS, and PMA differ with respect
to the cell type in which they can induce TNF-ca mRNA
expression, the distinct kinetics of TNF-a mRNA accumu-
lation when these inducers act on the same cell type, and
their differential interactions with metabolic inhibitors in the
same cell type (3). The study of TNF-a gene regulation there-
fore provides an opportunity to gain insight into the tran-
scriptional mechanisms whereby a single gene is induced by
distinct pathways.
The promoter sequences required for virus and LPS in-
duction of human TNF-a gene transcription have recently
been identified (15) . Although these sequences contain three
sites (tc1, x2, and rc3) that specifically bind the transcription
factor NF-KB in vitro, these sites are neither sufficient nor
required for virus or LPS induction of the gene in vivo (15).
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a B cell specific binding activity required for immunoglob-
ulin enhancer function (16) . Subsequent studies revealed that
NF-KB is present in many cell types, but it is located in the
cytoplasm in a complex with an inhibitory protein called I-KB.
Treatment of these cell types with a variety of inducers in-
cluding virus, LPS, and PMA leads to the disruption of the
NF-xB/I-KB complex, and the translocation ofactive NF-KB
to the nucleus where it is thought to be involved in the tran-
scriptional regulation of numerous genes (reviewed in refer-
ence 17) .
In this study the effect of PMA on the regulation of the
cloned human TNF-a gene introduced into cultured human
B and T cell lines has been analyzed . As in the case of virus
and LPS induction of the human TNF-a gene, K1-K3 are not
required for the gene's induction byPMA. Thus, unlike other
promoters containing NF-KB binding sites that are inducible
by virus, LPS andPMA, the induction of the human TNF-a
gene does not appear to be primarily mediated by NF-KB.
Moreover, the minimal sequences required for PMA induc-
tion ofTNF-a (-52 to +89 nucleotides [nt]t relative to the
mRNA cap site) differ from those minimal sequences required
for virus orLPS induction, and thus PMA induction is medi-
ated through distinct regulatory domains . We conclude that
TNF-a gene regulation by PMA, virus, and LPS is a very
complex process that involves multiple regulatory elements
and transcription factors that are active in a cell type specific
manner .
Materials and Methods
Cell Culture, Transfection, and Induction Protocols.
￿
HUT78, P30,
HPBALL, and Raji cells were grown inRPMI supplemented with
10% FCS, glutamine, penicillin, and streptomycin . Cells were trans-
fected employing lipofectin reagent (Bethesda Research Laborato-
ries, Bethesda, MD) (18), split into two aliquots 18 h after trans-
fection and maintained in RPMI and 10% FCS in the presence
or absence of 5 ng/ml ofPMA (Sigma Chemical Co., St . Louis,
MO) for 48 h . Bacterial chloramphenicol transferase (CAT) assays
(19) were performed . These assays were carried out at the time of
maximal level of expression postPMA induction (data not shown).
Cells used for RNA analysis or nuclear extract preparation were
maintained and induced with PMA as above.
RNAAnalysis.
￿
RNA was prepared from HUT78, P30, HPB-
ALL, and Raji cells. Uniformly "P-labeled probes were prepared
as described from SP6 -y-actin andT7TNFMBam (3) . The -y-actin
probe was made to have a specific activity that was five times less
than that of theTNF-a probe . The RNA fragments were electro-
phoresed on a 6% denaturing polyacrylamide gel as described (3) .
Subcellular Fractionation and Mobility Shift Electrophoresis .
￿
Nu-
clear extracts were prepared and binding assays were carried out
as described (20) and as detailed in the figure legends.
Plasmid Constructions.
￿
The TNF-a promoter CAT constructs
(-600, -576, -242, -199, -80, -52, and POCAT), p-l28ß
(x1)3, p-1280 (x2)4, p-l28ß (x3)6, p-61 TNF-a, p-61TNF-a (x1)3,
p-61 TNF-a (x2)3, p-61 TNF-a (x3)6 have been previously de-
' Abbreviations used in this paper; CAT, chloramphenicol trans£erase; MUT,
mutant ; nt, nucleotides; WT, wild type .
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scribed (15), as have been p-l28ß, 1280(PRDII)4 (21), and p-410
and p-410(PRDII)4 (22) .
Results
PMA Induction ofTumor Necrosis Factor (TNF}a mRNA
in Lymphocyte Cell Lines Is Cell Type Dependent . B and T
lymphocyte cell lines have previously been shown to display
different patterns of TNF-a mRNA expression in response
to PMA (3, 4, 6) . To determine whether TNF-a mRNA
expression and NF-KB binding activity could be correlated,
four T cell lines and the mature B cell Burkitt's lymphoma
cell line, Raji were compared . The T cell lines were chosen
because they represent distinct stages of differentiation as de-
termined by surface expression of lymphocyte antigens (23,
24) . The P30 cell line represents the earliest stage in T cell
differentiation (T-Blast 1) and is TdT+ (terminal transferase
activity), CD7+, and MHC class 11+ with no detectable y
or 6 T cell rearrangements (M. Krangel, personal communi-
cation). HPB-ALL (T Blast II) is TdT+, CD4+, CD8+, and
a$ TcR+ (24) . Jurkat (T Blast III) isVT +, CD4+, and aß
TcR+ (24) . HUT78 represents the most terminally 'acti-
vated' T cell phenotype (T-Blast V) and is TdT - , CD4 + ,
MHC class II+ and CD3+, but aß TcR- (24) .
These T and B cell lines were mock or PMA-induced and
accurately initiated TNF-a mRNA was determined as pre-
viously described (3) . In HPB-ALL and Jurkat cells no con-
Figure 1 .
￿
PMA induction ofTNF-a gene expression in humanT cell
lines. HUT78, HBP-ALL, P30, Jurkat, and Raji cells were either mock
(-) or PMA (+) induced and quantitative RNase mapping of TNF-ca
and 1'-actin mRNAs was carried out with 25 jug of total cellular RNA
as described (3) . The probeT7TNFMBam was used to map TNT-amRNA
levels and they-actin probe was used asaninternal control forRNA recovery
(3) . Both probes were uniformly labeled with 32P and the -y-actin probe
was made to have a specific activity that was five times less than that of
the TNF-a probe. Positions of the TNF-a and y-actin protected frag-
ments are indicated at right . The upper portion is a longer radiographic
exposure than the lower portion .
Human Tumor Necrosis Factor-a Gene Regulation in T and B Cell Linesstitutive or inducible TNF-a mRNA was evident (Fig. 1,
lanes 3, 4, 7, and 8), although a faint inducible band was
detected in both cell types after a long exposure of the auto-
radiogram (not shown) . TNF-amRNA was constitutively
expressed at low levels in P30 cells, but was not inducible
by PMA (lanes 5 and 6) . By contrast, in HUT78 and Raji
cells, TNF-acmRNA levels were highly inducible by PMA
(lanes 1, 2, 9, and 10) ; Raji cells in addition had high levels
ofconstitutive TNF-amRNA expression. We conclude that
constitutive and PMA induced TNF-a mRNA levels vary
substantially in theT cell lines tested andmay represent stage-
specific gene expression.
NF-KB Binding Activity Expression Does not Correlate with
Tumor Necrosis Factor (TNF}a mRNA Expression Patterns.
Three sequences within the 5' regulatory region of TNF-a
(K1, K2, and0; Fig . 2) specifically bind NF-KB in nuclear
extracts derived from lymphoid cells (15) . Although these
sites have previously been shown not to be required for virus
and LPS induction of the human TNF-a gene, it was pos-
sible thatPMA induction of the gene was mediated by NF-KB.
To determine whether NF-KB binding activity could be
correlated with TNF-amRNA expression, nuclear extracts
were prepared from mock or PMA induced HUT78, HPB-
ALL, P30, and Raji cells. Electrophoretic mobility shift assays
were performed using the NF-KB wild type (WT) binding
site from the murine K chain enhancer as a probe (25) . The
WT sequence bound a protein that was constitutively ex-
pressed in HUT78 (Fig . 3, lane 2) and Raji cells (lanes 8 and
10) . This binding activity was inducible in HUT78 (lane 3)
and HBP-ALL cells (lane 5), but as expected not further in-
ducible in Raji cells (lanes 8 and 9 ; see reference 16) . These
binding activities were efficiently competed byWT cold com-
petitor (lane 11), but not by a mutant (MUT) NF-KB site
(lane 12) that differs at nucleotides that are crucial forNF-KB
binding activity (25) . Thus, NF-KB binding activity did not
correlate with TNF-a mRNA expression (Fig . 1) .
NF-KB binding activity is thought to be present or induc-
ible in most if not all cell types (see reference 17 for review) .
Figure 2 .
￿
The human TNF-ot promoter contains three sites, K1, K2,
and K3 that specifically bind the transcription factor NF-KB. A diagram
of the human TNF-a promoter and the location of K1, K2, and K3 . The
rightward arrow indicates the site of initiation of transcription and the
numbers indicate the number of nucleotides (nt) upstream (-) or down-
stream (+) from the site of transcriptional initiation . The nucleotide se-
quences of the sites are displayed below. The arrows indicate whether the
site occurs on the coding (rightuutd) or noncoding (leftuurxi) strand. Asterisks
(*) note divergence from the consensus KB element as compiled by Lenardo
and Baltimore (17) .
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Figure 3 .
￿
Gel shift experiment with T cell nuclear extracts, using the
chemically synthesized NF-KB wild type (WT) element as a probe . Assay
mixtures contained either no extract (lane 1) or 5 kg of nuclear extract
protein from unstimulated (-) orPMA induced (+)HUT78 (lanes 2and
3), HPB-ALL (lanes 4 and 5), P30 (lanes 6 and 7), or Raji cells (lanes
8-12) . NF-KBWT and mutant (MUT) oligonucleotides were usedas probes.
Binding assays were carried out as describedin reference 20 and the NF-KB
WT and HUT oligonucleotides are described in reference 25 .
The absence of NF-KB binding activity in P30 nuclear ex-
tracts treated or untreated with PMA under the conditions
studied was therefore surprising (Fig. 3, lanes 6 and 7) . It
will be interesting to test whether other immature T cell
lines of the same phenotype as P30 cells also display a lack
ofPMAinduced NF-KB binding activity. Such cell lines how-
ever are not yet available for study.
Taken together with the mRNA expression results dis-
cussed above, we conclude that NF-KB binding activity is
not necessary for constitutive expression ofTNF-a . P30 cells
display no such binding activity (Fig . 3, lane 6), but express
TNF-amRNA constitutively (Fig . 1, lane 5) . In addition,
PMA inducible NF-KB binding activity is not sufficient for
significant TNF-amRNA expression . HBP-ALL cells dis-
play PMA inducible NF-KB binding activity (Fig. 3, lane 5),
but only barely detectable TNF-amRNA induction byPMA
(Fig . 1, lane 4) . However, the T cell type in which TNF-a
gene transcription was most highly inducible, HUT78 (Fig .
1, lanes 1 and 2), displayed high levels of constitutive and
inducibleNF-KB binding activity (Fig. 3, lanes 2 and 3). Simi-
larly, Raji cells constitutively express a high level ofTNF-a
mRNA that is further inducible by PMA (Fig. 1, lanes 9
and 10) . Moreover, Raji cell nuclear extracts display high levels
of constitutive NF-KB binding activity (Fig . 3, lanes 8 and9) . It was therefore possible that although NF-KB was not
a primary mediator ofTNF-a gene transcription in certain
cell types, it could be in other cell types. We were therefore
interested in determining whether in HUT78 and Raji cells,
K1-K3 and NF-KB played a functional role in PMA induced
TNF-a gene regulation .
K1, K2, and K3 Are not Requiredfor PMA Induction of Tumor
Necrosis Factor (TNF}a in HUT78 or Raji Cells. To deter-
mine the functional contribution of K1, K2, and K3 to the
transcriptional expression ofTNF-a inHUT78 and Raji cells,
5' deletionTNF-a promoterCAT fusion constructs that pro-
gressively deleted K1-K3, were transfected into these cell types
(Fig. 4 A and B) . Deletion of each of the sites K1-K3, had
little effect on the induction ratio of the promoter by PMA
in either cell type (Fig. 4A and B) . Moreover, the -80 TNF-a
CAT fusion, in which all three of the NF-KB binding sites
have been deleted, is still inducible byPMA in both cell types
(Fig. 4 A and B, lanes 9-12) . Similarly, this -80 TNF-a
construct was inducible in Jurkat cells, which also display
NF-KB binding activity (data not shown) . We conclude that
the NF-KB binding sites from the TNF-a promoter, K1-K3,
are not required forPMA induction ofhumanTNF-a gene
transcription .
Figure 4 .
￿
PMA induction of human TNF-a promoter /CAT fusions
in lymphocyte cell lines. Autoradiogram shows results of CAT assays of
extracts prepared from HUT78 (A) or Raji (B) cells transfected with 5'
deletion constructs of the human TNF-a/CAT fusion reporter gene di-
agrammed in the figure. Arrows indicate the direction ofthe binding site
relative to the direction of transcription . Cells were transfected and mock
or PMA induced and CAT assays were performed as described in the
Materials and Methods section .
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Although K1-3 are not required for PMA induction of
TNF-a gene transcription, they and other TNF-a promoter
sequences have transcriptional activities that vary with cell
type. For example, maximal levels of constitutive and induced
CAT activity are observed when -199 nt relative to the
TNF-a mRNA cap site are present in HUT78 cells (Fig.
4 A, lanes 5-8) . Similarly, maximal levels of induced CAT
activity are observed when -199 nt ofTNF-a 5' sequence
are present in Raji cells (Fig. 4 B, lane 8) . However, maximal
constitutive levels in Raji cells require the sequences between
-242 and -199 that contain K2 (Fig . 4 B, lanes 5-8) . Of
interest, in HUT78 cells, the largest drop in CAT levels is
observed when the sequences between -199 and -118 are
deleted (Fig . 4 A, lanes 7-10) . Deletion of these sequences
has a smaller effect in Raji cells (Fig . 4 B, lanes 7-10) . An-
other slight drop in induced CAT levels occurs in bothHUT78
and Raji cells when the sequences containing K3 are deleted,
but the -80 TNF-a CAT fusion, is still highly inducible
by PMA in both cell types (Fig. 4A and B, lanes 9-12) . Of
note, three other putative NF-KB binding sites are located
between -1045 and -608 nt relative to the TNF-ca cap site .
When a 1045 TNF-a CAT construct was compared to a
-608 TNF-a CAT construct in the presence or absence of
PMA, little difference in constitutive or induced CAT activi-
ties could be discerned (data not shown) . Thus, PMA induc-
tion ofTNF-a gene transcription, like virus andLPS induc-
tion, is not primarily mediated through NF-KB.
Multimers ofK1, K2, K3 andPRDII Confer Inducibility on the
Heterologous (3-globin Promoter in Raji but not in HUT78
Cells. To determine whether multimers of K1, K2, and K3
were capable of acting like other PMA inducible NF-KB
binding sites in vivo (see reference 17 for review), constructs
containing multimers ofthese sequences upstream from a -128
a-globin promoter fused to the CAT reporter gene were trans-
fected into Raji and HUT78 cells (Fig. 5 A and B) . Surpris-
ingly, multimers of K1, K2, and K3 acted as PMA inducible
elements when tested in Raji cells but not in HUT78 cells
(Fig. 5 A and B, lanes 1-8) . Cell type specific activity of
these multimers had previously been reported (15) . They in-
creased basal transcription of the -128 (3-globin promoter
in each case inmouse fibroblast L cells but had no effectwhen
tested in mouse monocyte P388D1 cells. Multimers of K1,
K2, and K3 were not capable of conferring virus or LPS in-
ducibility on the -128 f3-globin promoter in either L or
P388D1 cells (15) .
PRDII is a critical element involved in the virus induction
of the IFN-0 gene that has been shown to specifically bind
to NF-KB and to mediate virus (26-28) and LPS induction
(15) . When four copies ofPRDII are fused to either the -128
a- or -41 R-globin promoter, basal and PMA inducedCAT
activity is greatly increased in Raji cells (Fig . 5 A, lanes 9,
10, 13 and 14) . In HUT78 cells by contrast, although four
copies ofPRDII did greatly increase constitutiveCAT levels,
they did not confer PMA inducibility on either the -128
or -41 ~-globin promoter (lanes 9-14) . Thus, the in vivo
functional role ofNF-KB elements in constitutive and PMA
induced transcriptional expression is cell type specific .
Moreover, the function of multimers of K1-3 and PRDII is
Human Tumor Necrosis Factor-a Gene Regulation in T and B Cell LinesFigure 5 .
￿
Transcriptional activities ofmultiple copies ofK1, ic2, a3, and
PRDII on a heterologous promoter in lymphocyte cell lines. Autoradio-
gram shows results ofCAT assays of extracts prepared from Raji (A) or
HUT78 (B) cells transfected with the reporter genes diagrammed in the
figure. Cells were transfected and either mock (-) orPMA (+) induced
as describedabove. We note that both the -128 /3-globin and -41 /3-globin
promoters were minimally inducible by PMA .
not strictly correlated with in vitroNF-KB binding activities
in a particular cell type .
Multimers of«l, a2, and id Do not Increase Transcription when
Fused to a Truncated Tumor Necrosis Factor (TNF}a Promoter .
By contrast to the -128 /3-globin promoter, The truncated
-61 TNF-a promoter is highly inducible by PMA in Raji
cells (Fig. 5 A and Fig. 6, lanes 1 and 2) . In the context of
the -61 TNF-a promoter however, multimers of K1-a3 had
no effect on either constitutive or induced transcription (Fig.
6, lanes 1-8) . This result is consistent with the deletion data
presented above; deletion ofeach ofthe sites, K1-K3, had little
effect on the gene's inducibility by PMA (Fig . 4 B) . Simi-
larly, multimers of ic1-3 fused to the -61 TNF-a promoter
also did not augment transcription inHUT78 cells (data not
shown) . Promoter context has previously been shown to be
an important variable in the function of the multimers K1-
K3 . In P388D1 cells for example, multimers of rc2 augmented
basal transcription of the -61 TNF-a promoter but not of
the -128 /3-globin promoter (15) . Similarly, the influence
of sequence context on the ability of NF-KB binding sites
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Figure 6 .
￿
Transcriptional activities ofmultiplecopies ofal, a2, a3, PRDII
on a truncated TNF-a promoter in Raji cells . Autoradiogram shows results
of CAT assays of extracts prepared from Raji cells transfected with the
reporter genes diagrammed below. Cells were transfected and either mock
(-) or PMA (+) induced as described above.
to act as inducible transcriptional activators has also been
demonstrated. An NF-KB binding site required for PMA in-
duction of IIT2R-a chain gene does not activate transcrip-
tion from a heterologous promoter, and sequences immedi-
ately adjacent to this site are critical for the gene's induction
by PMA (29) . We conclude that the in vivo function of the
NF-KB binding sites K1-K3 is dependent on the cell type and
sequence context in which they are studied .
- 52 nt 5' to the Tumor Necrosis Factor (TNF)-a mRNA
Cap Site Are SufficientforPMA Induction in Raji andHUT78
Cells. To determine whether the minimal sequence require-
ments for PMA induction ofTNF-a are identical to those
required for virus orLPS induction ofthe gene, a -52 TNF-a
promoter CAT fusion construct was transfected intoHUT78
and Raji cells (Fig. 7A and B) . This -52 construct was trans-
fected into HUT78 and Raji cells (Fig . 7 A and B, lanes 5
and 6) . Deletion of the sequences between -80 and -52
nt caused a decrease in both constitutive and PMA induced
CAT levels in both cell types (Fig. 7 A and B, lanes 5 and
6) . However, the decrease in induction ratio when these se-
quences were deleted was greater in Raji than in HUT78
cells (Fig . 7 A and B, lanes 3-6) .
By contrast, the -52 TNF-a construct was not inducible
by virus or LPSwhen studied in L and P388D1 cells . Moreover,
the minimal sequence requirements for virus induction of
TNF-a gene transcription are cell type specific and differ in
L cells where -61 nt are required and in P388D1 cells where
-118 nt 5' to the TNF-amRNA cap site are required . LPS
induction of the gene in P388D1 cells also requires -118 nt
5' to the TNF-camRNA cap site. Deletion of the sequences
between -61 and -52 nt abolished virus inducibility in L
cells and decreased the constitutive expression of the gene
inP388D1 cells (15) . We conclude that the minimal sequencesFigure 7 .
￿
-52 nt 5' to the TNF-a transcription start site are sufficient
forPMA induction of the human TNF-a promoter in human lymphocyte
cell lines. Autoradiogram shows results of CAT assays ofextracts prepared
from Raji (A) or HUT78 (B) cells transfected with a -80 TNF-a/CAT
and -52 TNF-ca/CAT constructs that are diagrammed in Fig . 4 and
POCAT, a promoterless CAT construct . Cells were transfected and either
mock (-) or PMA (+) induced as described above.
required for PMA induction of thehumanTNF-a gene differ
from those required for virus andLPSinduction of the gene
and therefore these processes are mediated through different
promoter sequences and probably through different transcrip-
tion factors.
Discussion
Transient transfection of a 5' promoter deletion series of
the human TNF-a gene has identified sequences necessary
for maximal constitutive andPMA induced expression ofthe
gene in a human B and T lymphocyte cell line . Although
there are three sequences in the upstream flanking sequences
ofthehuman TNF-a gene that can specifically bind the tran-
scription factor NF-KB in lymphoid nuclear extracts (15), these
sequences are not required for PMA induction of the gene .
Moreover, PMA inducibility ofTNF-a mRNA is not cor-
related withNF-KB binding activities in various T andB cell
lines . Taken together with results that demonstrate that u1-a3
are not required for virus and LPS induction, we conclude
that TNF-a gene regulation is not primarily mediated by
NF-KB . Thus, unlike other genes that are inducible byPMA,
virus, orLPS (reviewed in reference 17, 30, and 31) that con-
tain NF-rcB binding sites, induction of human TNF-ac gene
transcription is not accomplished through these sites .
The humanTNF-a gene 5' flanking sequences contain six
regulatory regions that span the sequences from -600 to +89
nt relative to the mRNA transcription start site.(Fig. 8) . Re-
gion I spans the sequences between -52 and +89 and is
sufficient for PMA induction of the gene in both Raji and
HUT78 cells (Fig. 7A and B) . Potential regulatory domains
in Region I include a purine rich region at -40 nt reminis-
Figure 8 .
￿
Human TNF-a gene regulatory sequences. A diagram showing
the sequences required to see virus induction in mouse L929 cells, virus,
and LPS inductionin mouseP388D1 cells andPMA induction in the human
T cell line HUT78 and the human B cell line, Raji are indicated by the
solid lines . The rightward arrow indicates the site of initiation of tran-
scription and the numbers indicate the number of nucleotides (nt) up-
stream (-) or downstream (+) from the site of transcriptional initiation .
The location ofthe NF-rsB binding sites, u1, ic2, and ic3 and two putative
SpI binding sites are indicated . The six open boxes between -600 and
+89 relative to the transcription start site indicate regulatory regions desig-
nated I-VI .
cent of purine boxes active in Ilr2 gene transcription (32)
and a region at - 24 nt that shares some similarity with the
multi-response element, a site involved in the phorbol ester,
IL1, TNF-ci, and forskolin induction of the IIr6 gene pro-
moter (33) . Region II includes the sequences between -61
and -52 and are required together with Region I to mediate
virus induction of the gene in L cells (15) . A putative SpI
binding site at -54 nt overlaps Regions I and II (Fig . 8) .
Region III includes the sequences between -80 and -61 .
Deletion of Regions II and III together results in a decrease
in constitutive and PMA induced promoter activity (Fig. 7
A and B) . Deletion ofthese regions also results in a decrease
in constitutive activity in P3881)1 and L cells and the loss
of virus inducibility in L cells (15) .
Region IV includes the sequences between -118 and -80
nt and contains the u3 site. Its deletion results in a slight
decrease ofPMA induced activity in both Raji and HUT78
cells with little effect on the induction ratio (Fig . 4A and
B) . When studied in L cells, its deletion causes an approxi-
mately threefold decrease in virus induced mRNA levels,
whereas in P3881)1 cells there was a slight increase in consti-
tutive activity in P388DI cells, and LPS or virus induction
of the gene could no longer be detected (15) . Region V in-
cludes the sequences between -199 and -118 nt and its de-
letion results in an approximately two-fold decrease in both
constitutive andPMA induced CAT activity inHUT78cells
(Fig . 4), but has negligible effect in Raji cells (Fig. 5) . In
both L and P3881)1 cells, deletion of Region V results in
an approximately three- to five-fold decrease in constitutive
and virus and LPS induced activity (15) . A second putative
Sp1 binding site occurs in Region V at -160 nt (Fig . 8) .
Neither this site or the SpI site at -54 nt are necessary to
detect induction of the TNF-a promoter byPMA, they may
however contribute to levels of transcription . Region VI in-
cludes the sequences between -600 and -199 and contains
«1 and a2 . Sequences included in Region VI contribute to
levels of constitutive activity in Raji cells (Fig . 4 B), L and
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(Fig. 4 A) and virus and LPS induced levels in P388D1
cells (15) .
We conclude that Regions I-V (-199 to +89 nt relative
to the TNF-ci mRNA cap site) are sufficient for maximal
induction ratio of TNF-a gene transcription resulting from
PMA, virus, or LPS treatment in the various cell types tested.
However, the minimal sequence requirements for induction
of the gene by PMA, virus, and LPS differ. We were unable
to compare the sequences necessary for virus and LPS induc-
tion of TNF-ci to those required for PMA induction in
HUT78 and Raji cells because we could not detect induc-
tion of the promoter CAT constructs by virus or LPS in these
cell types (data not shown).
Previous studies have delineated sequences involved in PMA
induction of the human TNF-a gene in other cell types (34,
35). In one of the studies, a 185 nt region spanning sequences
from -295 to -110 nt was found to be required for PMA
induction of the gene and a -101 TNF-cx promoter CAT
fusion was found not to be PMA inducible in K562 cells(34).
This is in contrast to our findings and to those of another
study in which the gene was analyzed in U937 cells (35) .
In the latter study, PMA induction of TNF-ci was localized
to a region between -95 and -36 nt upstream of the tran-
scription start site (35). These differences suggest that se-
quence requirements for PMA induction of TNF-at may be
cell type specific. We note that the sequence requirements
for virus induction ofTNF-ci gene transcription are cell type
specific (15) . This may reflect cell type specific differences in
the amounts or types of transcription factors that interact
with the promoter in the different cell types.
Surprisingly, multimers of K1-K3, and PRDII, when fused
to a heterologous promoter, can act as PMA inducible tran-
scriptional activators in a B cell (Raji) but not a T cell line
(HUT78) and therefore are active in a cell type specific manner.
However K1-K3, when fused to a truncated TNF-ci promoter,
do not augment basal or PMA induced transcription in ei-
ther cell type. Possibly, proteins that bind to sequences down-
stream of -61 nt in the TNF-ca promoter and that are in-
volved in PMA induction interfere with the binding ofNF-KB
to 0-0. In this way these sequences and the transcription
factors that interact with them couldinterfere with the ability
of K1-K3 to act as PMA inducible KB enhancer elements. These
observations emphasize the importance of sequence context
and cell type in the determination of promoter element
function.
It is also important to note that different genes may be
activated by common regulatory elements and factors, but
these components that are necessary may not be sufficient
to activate transcription. For example, multiple copies of the
PRDII element from the IFN-0 promoter are activated by
virus (21),LPS (15), and PMA (Fig. 5 A), presumably achieved
at least in part through interactions with NF-KB (15, 26-28).
However, the intact IFN-a promoter which only contains
one copy of PRDII, responds to virus (21), but not to LPS
(15) or PMA (3). The lack of LPS and PMA induction of
the intact IFN-(3 gene is probably due to the requirement
of synergistic interactions between PRDII and another pro-
moter element and/or the involvement and release of nega-
tive control. Thus, the specificity of transcriptional activa-
tion of inducible genes in particular cell types is probably
achieved by a unique combination of regulatory sequences
and a corresponding unique set of binding activities that are
activated by a particular inducer.
TNF-a activates three KB binding proteins in primary T
cells (11), and acts via KB sequences to induce the expression
of the IL2R-a, IL2, and IL-6 genes (11, 29, 30) . TNF-a
has also been reported to autoinduce its own transcription
in HL-60 cells (36); we were however unable to detect any
effect of exogenously added TNF-a protein on TNF-ci gene
expression in the B and T cell lines studied here (data not
shown) . TNF-ci also stimulates HIV-1 expression from la-
tently infected cell lines either by direct activation of TNF-a
responsive sequences within the viral genome (8) or via other
mediators such as IL-6 (37), a potent B cell growth factor.
Thus, TNF-a may be an important mediator of the poly-
clonal B cell expansion associated with AIDS and activation
of HIV expression associated with the progression of dis-
ease. The understanding of TNF-ci gene regulation and the
role of TNF-a in the activation and differentiation of lym-
phocytes should therefore enhance our knowledge of both
the mechanisms of HIV pathogenicity and of inducible gene
expression.
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